At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 7 enrolled
Drug / intervention
Copper IUD ( ParaGard Intrauterine Contraceptive Device)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Acceptability and Technical Feasibility of Insertion of a Copper IUD at Time of Elective C-section: A Pilot Study
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center·interventional·Posted Aug 13, 2008·Updated Aug 11, 2014
In Brief
A Phase 4 clinical trial evaluating Copper IUD ( ParaGard Intrauterine Contraceptive Device) for Contraception. Completed, enrolled 7 participants across 1 site.
Detailed Summary
This is a pilot study of up to 10 women, which will test the hypothesis that the placement of copper IUDs through the uterine incision at the time of uncomplicated elective C-section is technically feasible and acceptable to women seeking long-term contraception.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsContraception
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 2007
First PostedAug 2008
Primary CompletionSep 2008
TodayJul 2026
First PostedAug 13, 2008
Enrollment StartNov 1, 2007
Primary CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 17.9 years ago
Interventions
Copper IUD ( ParaGard Intrauterine Contraceptive Device)device
Intraoperative placement of copper IUD at time of C-section